Skip to content
OpenCapital
Get started

Acurx Pharmaceuticals, Inc. ACXP Q4 2024 Annual earnings

Reported March 17, 2025 · Before market open

EPS-$0.16Beat by $0.02
EPS estimate-$0.18

Next report

Aug 14, 2026 (In 2 weeks)
EPS estimate-$0.42

Versus estimates

Diluted EPS

Q1 2026-$0.62Miss by $0.03Q4 2025-$0.31Beat by $0.70Q3 2025-$1.23Beat by $0.38Q2 2025-$1.89Beat by $0.11Q1 2025-$2.20Miss by $2.05
Q4 2024-$0.16Beat by $0.02

Ask the moment Acurx Pharmaceuticals, Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Acurx Pharmaceuticals, Inc. report Q4 2024 earnings?
Acurx Pharmaceuticals, Inc. (ACXP) reported Q4 2024 earnings on March 17, 2025 before market open.
What were Acurx Pharmaceuticals, Inc.'s Q4 2024 revenue and EPS?
Acurx Pharmaceuticals, Inc. reported eps of $-0.16 for Q4 2024.
Did Acurx Pharmaceuticals, Inc. beat estimates in Q4 2024?
EPS beat the consensus estimate of $-0.18 by $0.02.
Where can I find Acurx Pharmaceuticals, Inc.'s Q4 2024 SEC filings?
You can read the 10-K periodic report (0001558370-25-003117) directly on SEC EDGAR. The filing index links above go to sec.gov.